Earnings Feed
Start Free
Coherus BioSciences, Inc.·4

Feb 5, 7:03 PM ET

Wahlstrom Mats 4

4 · Coherus BioSciences, Inc. · Filed Feb 5, 2024

Insider Transaction Report

Form 4
Period: 2024-02-01
Coherus BioSciences, Inc.CHRS
Wahlstrom Mats
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-01$1.67/sh+44,991$75,000→ 99,988 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-02-01−44,991→ 0 total
    Exercise: $1.67Exp: 2024-03-10→ Common Stock (44,991 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-02-01−14,997→ 0 total
    Exercise: $1.67Exp: 2024-03-10→ Common Stock (14,997 underlying)
  • Exercise/Conversion

    Common Stock

    2024-02-01$1.67/sh+14,997$25,000→ 54,997 total
Footnotes (2)
  • [F1]This represents a cash exercise-and-hold transaction where cash was paid by the Reporting Person for the exercise price.
  • [F2]The option is fully vested and exercisable.

Documents

1 file
  • 4
    form4.xmlPrimary